Interleukin-6 predicts inflammation-induced increase of glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism
Regulatory authorities do not approve it for human or veterinary use
GLP-1RAs improve risk factors for CV disease, including weight loss, blood glucose control, blood pressure reduction, and lipid improvement
Zhou, Y., Zhang, Y., Wang, L., & Wang, Y
Keep your injection away from the refrigerator door where temperature fluctuations occur each time the door opens and closes
Looking more closely at the balance between efficacy and safety for each drug, while considering dosing titration strategies, we compare safety based on adverse event (AE) rates, AE-related discontinuation rates, and rates of nausea and vomiting